The A45 Study: Combination anti-amyloid therapy for preclinical Alzheimer's disease
09/30/2019 - 05/31/2024 (Subcontract PI)University of Southern California NIH NIA5R01AG061848-02
The A3 Study: Ante-Amyloid prevention of Alzheimer's disease
06/01/2019 - 04/30/2023 (Subcontract PI)University of Southern California NIH NIA1R01AG061848-01
Protocol number BAN2401-G000-303: AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subject
01/01/2020 - 12/31/2022 (Subcontract PI)University of Southern California Eisai, Inc
Clarifying the Role Played by Microglia and Astrocyte Activation in Veterans with Gulf War Illness Using Positron Emission Tomography (PET)
09/30/2019 - 09/29/2022 (PI)Department of Defense/Army Medical Research Acquisition Activity
Assessing the perivascular clearance of brain debris in familial and sporadic Alzheimer's disease
09/01/2020 - 08/31/2022 (Subcontract PI)The Brigham and Women's Hospital, Inc. BrightFocus Fdn
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
09/15/2016 - 07/31/2022 (Subcontract PI)University of Southern California NIH NIA2U19AG024904-11
ADNI-DOD-TAU, Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans using ADNI
09/22/2016 - 09/21/2021 (Subcontract PI)University of Southern California DOD Army Med Resrch
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease
04/30/2019 - 04/30/2021 (PI)Vielight Inc.
Human Neurobiology Laboratory Support Contract with Pfizer
01/01/2014 - 12/31/2018 (Co-Investigator of Sub-Project / SP)
PI: Kevin C. Thomas, PhDPfizer, Inc.
Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)
08/24/2015 - 03/31/2018 (Subcontract PI)University of Southern California NIH NIA
Showing 10 of 14 results.
Show All Results